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Online monitoring in continuous renal replacement therapies. chines for chronic patients (Table 3). The scope of this
Technical improvements in dialysis equipment for chronic he- technology is to achieve information in real time on the
modialysis patients has mirrored improvements in continuous efficiency of the system and on the urea kinetic parame-renal replacement therapies (CRRTs) for patients with acute
ters relevant to the dialysis session (abstract; Keshaviahrenal failure who are critically ill. This article reviews the avail-
et al, J Am Soc Nephrol 3:374, 1992; abstract; Depner et al,able types and importance of online monitors such as urea sen-
sors to provide real-time urea kinetic parameters, temperature J Am Soc Nephrol 4:343, 1993) [21–35]. The technology is
sensors to target thermal balance throughout each session, con- based on the analysis of the spent dialysate leaving the
ductivity measurement of sodium balance in the dialysate, blood
dialyzer (Baxter Biostat 1000; Gambro UQM, Hospalvolume monitoring to aid against cardiovascular instability and
Diascan, UM Fresenius, Bad Homburg, Germany) or oftreatment-induced hypotension, biofeedback systems, and re-
mote dialysis/teledialysis for efficient use of trained personnel. the ultrafiltrate produced in a hemofiltration unit (UMS
Bellco, Mirandola, Italy). All of these sensors use the
enzymatic reaction promoted by urease that leads to
Continuous renal replacement therapies (CRRTs) are formation from urea molecules of ionic species that can
today considered a well-tolerated and efficient group of be measured in a conductivity cell [36]. Because the same
treatments for acute renal failure in critically ill patients measurement is done on the fluid before the passage
[1–3]. The evolution in technology of CRRT has only through the enzyme, the differential conductivity mea-
partially followed the more sophisticated evolution that surement can provide information on the amount of urea
took place in the equipment for chronic hemodialysis removed. All of these monitors offer a series of calcula-
patients [4–10]. In such patients, the increased morbidity tions of urea kinetic parameters, and they are also capa-
and the progressively increased age require a gentle and ble of presenting a predicted result for the session. In
carefully monitored hemodialysis therapy [11–20]. To this way, the operator can modify the operational param-
achieve such results, online monitoring of patient and eter to achieve the desired results.
machine parameters may become an important issue, This technology has not been used for CRRT machines,
although it includes some practical considerations (Table and it has not been applied to acute patients treated with
1). Different parameters could be monitored according continuous therapies. The slow progressive removal of
to the technical and clinical requirements (Table 2). solutes in CRRT permit an equilibrium between removal
Based on the available technology, some techniques for and generation to be reached, so that constant blood
online monitoring in dialysis have been developed, includ- levels can be observed at a steady state. Under these
ing urea sensors, temperature sensors, blood volume sen- circumstances, the need for online measurement of urea
sors, and teledialysis or biofeedback systems. This review kinetic parameters is not required, and daily or twice
attempts to analyze how this new technology could have daily blood chemistry measurements should be sufficient
a positive impact in acute patients and how it could be to describe and monitor treatment efficiency. Therefore,
implemented in the present equipment for CRRT. the use of online monitors for urea or other solutes in
these patients may not represent a significant advantage,
and we do not foresee the use of urea sensors in CRRT,ONLINE UREA MONITORING
at least in this generation of machines [37].There are several urea sensors available on the market
that are generally integrated in the hemodialysis ma-
ONLINE TEMPERATURE SENSORS
This technology has mostly been proposed by FreseniusKey words: acute renal failure, critical care monitoring, urea kinetics,
blood chemistry. as part of the latest generation of dialysis machines for
chronic patients. The technology consists of the placement 1999 by the International Society of Nephrology
S-8
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Table 1. Aspects of on-line monitoring in CRRT
•Invasivity
• Frequency of measurement
• Accuracy of measurement
• Technology involvement
• Cost of the required hardware
• Cost of the required disposable
• Cost of the software
• Significance of the monitored parameter
Table 2. Parameters that could be monitored on-line
Fig. 1. Typical thermal energy balance in hemodialysis. The blood
temperature monitor (BTM) consists of two sensors placed on thePatient Treatment
arterial and venous line of the extracorporeal circulation.
• Arterial blood pressure and O2 • Blood and dialysate flow rates
• Heart rate and ECG • Extracorporeal circuit pressures
• Hydration and nutrition • Access condition and
recirculation
ONLINE CONDUCTIVITY MEASUREMENT• Whole body clearances (urea) • Efficiency (dialysance, Kt/V)
• Blood volume changes • Ultrafiltration rate and control The use of conductivity cells on the inlet and outlet• Electrolytes and acid-base • Effective delivery (blood
dialysate lines has been proposed not only to achieveprocessed)
• Energy and thermal balance • Dialysate quality ionic dialysance and therefore to monitor treatment effi-
(HFD-OLHDF) ciency, but also to provide accurate information on so-• Bioincompatibility reactions • Dialysate composition and
dium balance. This could only be seen as passive andtemperature
retrospective information. However, in a system in which
the sodium concentration of inlet dialysate (or replace-
ment solution) could be varied manually or automati-
Table 3. On-line urea monitoring systems cally, this may represent a tool to target the final sodium
Name Company System balance or to set a predetermined sodium concentration
that should be reached by the patient at the end of theBiostat 1000 Baxter Repeated measurements of spent dialysate
UMS Bellco Continuous measure of blood ultrafiltrate session. Thanks to detailed information collected by such
DQM Gambro Continuous measure of dialysate spill off a system, modifications in the composition of dialysateDiascan Hospal Based on ionic dialysance
or replacement solution may be actuated in order toUrea module Fresenius Based on ionic dialysance
correct electrolyte imbalances, vascular tone and reactiv-
ity, extracellular fluid volume, and composition. This,
however, would require an online preparation of the
of isolated temperature sensors on the arterial and ve- solutions for dialysate or replacement from treated water
nous line of the extracorporeal circulation. This equip- and concentrated salts. This technology is on its way,
ment not only allows for the calculation of the thermal and has already been applied in the chronic patient.
balance in a single session, but it also permits achieve- Future developments may likely include the application
ment of a target value of body temperature in the patient of this technology to the critically ill patient.
at the end of the session (Fig. 1). This is obtained by a
controlled variation in the temperature of the dialysis
BLOOD VOLUME MONITORINGsolution. The possibility of delivering a thermal bolus by
injection of cold saline in the venous line or by a sudden Cardiovascular instability, hypotension, and shock
represent a frequent complication of extracorporeal re-decrease in the temperature of dialysate allows for the
measurement of the recirculation in the vascular access. nal replacement therapies. Such events have been corre-
lated with the rate of ultrafiltration obtained during ther-This feature of the blood temperature monitor (BTM)
would be of great interest for the acute patient, since apy. In particular, when the ultrafiltration rate exceeds
0.25 ml/min/kg, the chance of hypotensive episodes in-the critically ill patient may frequently be hyperthermic,
and he or she may require a progressive cooling to im- creases exponentially [5]. The pathophysiological foun-
dations of this complication are based on a discrepancyprove hemodynamic stability and to prevent thermal
damage. On the other hand, when large volumes of fluid between the speed of fluid extraction by the artificial
membrane and the rate of intravascular refilling fromare exchanged in hemofiltration, the risk of a negative
thermal balance is greatly enhanced. For all of these the interstitial and intracellular space. Such a refilling is
dependent on myocardiac function, vascular permeabil-aspects, the use of BTM in the acute patient should be
probably encouraged, and future application of these ity, and oncotic power of plasma in the presence of an
intact endothelial barrier. Because such a discrepancymonitors in CRRT machines is highly recommended [38].
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results in significant circulating blood volume variations, with a blood flow of 200 ml/min for a total of 24 hours.
A total of 48 liters of ultrafiltrate was produced with anonline monitors have been designed to evaluate relative
blood volume changes during extracorporeal treatments average ultrafiltration rate of 2 liter/hr. The replacement
solution contained 140 mEq/liter of sodium and bicar-and to obtain directions for intravenous infusions in real
time. These monitors are based on different methods, bonate as a buffer. The net ultrafiltration was scheduled
according to the weight loss requirements.but they are all characterized by the capability of obtaining
an accurate measurement of relative blood volume varia- Hydration status was stabilized before the study, and
in both treatments, the patients required an average vol-tions. Because red blood cell mass and hemoglobin can-
not change during treatment, relative changes in the ume of ultrafiltration of approximately 3 liter/24 hr.
Both treatments were monitored with a continuousconcentration of hemoglobin or hematocrit must be re-
lated to a variation of blood water content. As a conse- arterial blood pressure recording (radial artery) and con-
tinuous blood volume measurement (Fig. 2). The moni-quence, variations of circulating blood volume can be
derived in a percentage. tor is characterized by two components: the sensor and
the display unit. The sensor is in the form of a clipCardiovascular instability and treatment-induced hy-
potension may be even more frequent in critically ill that is applied to the prefilter line of the extracorporeal
circulation. A special disposable transparent cell is con-patients with acute renal failure. To prevent vascular
instability and dialysis-induced hypotension, CRRTs, in- nected to the line before the hemodialyzer, and the sen-
sor clip is placed exactly on this cell. The sensor operatesstead of daily intermittent hemodialysis (DIHD), have
been used in such patients. Improved clinical tolerance by sending a light beam across the transparent cell inside
which blood is flowing. Because of the defined frequencyis ensured because of a slow continuous ultrafiltration
over an extended period of time. For example, assuming of the light beam and the red cells’ tendency to reflect the
light, the sensor clip can detect even minimal scattereda fluid input of 4000 ml/24 hr in a completely anuric
patient in the intensive care unit (ICU), the ultrafiltration variations caused by changes in the hematocrit concen-
tration. The sensor is then connected by a cable to therate required to restore an adequate fluid balance would
be of one order of magnitude less in CRRT than in a daily monitor that reports blood volume changes in real time
on a graphic display. The method has been previouslyfour-hour hemodialysis session (2.7 ml/min in CRRT vs.
16.6 ml/min in DIHD). Therefore, in CRRT, intravascu- validated, and it permits detection of even slight varia-
tions in hematocrit reflecting parallel variations in circu-lar refilling may likely take place at a speed that is ade-
quate in preventing significant variations of circulating lating blood volume. It should be noted that other BVMs
are available on the market, but most of them are partblood volume. Blood volume monitors have been used
in the critically ill patients by our group. of a chronic dialysis machine and are not a self-standing
unit. For this reason, we selected the Crit-Line in orderWe carried out a prospective randomized cross-over
study on 10 patients with acute renal failure treated in to apply the monitor to our CRRT machines manufac-
tured by different companies.a random sequence with a 4-hour hemodialysis session
(DIHD) and a 24-hour continuous venovenous hemo- Table 4 reports the metabolic data and clinical param-
eters recorded before and after the different treatments.filtration (CVVH) session. In all cases, a special device
(Crit-Line; In-line Diagnostics, Salt Lake City, UT, USA) Due to the intermittent nature of DIHD, the results
achieved refer to an average treatment time of 230 6 15was used to detect online blood volume changes and to
correlate these changes with the patient’s hemodynamic minutes. In contrast, the CVVH results refer to a mean
treatment duration of 1400 6 80 minutes. As a conse-response. Patients were admitted to the nephrology ward
and/or ICU. Acute renal failure originated from different quence, wide shifts in biochemistry profiles are seen in
DIHD compared with the more steady conditions re-causes (6 postsurgical and 4 toxic nephropathy). During
treatment, careful attention was paid to prevent varia- corded in CVVH.
As reported in Figure 3, a significantly higher bloodtions in body temperature and baseline vasopressor
pharmacological treatment. The intermittent hemodialy- pressure drop is observed during the intermittent hemo-
dialysis session in all patients. The difference in maximalsis session was performed for four hours with a blood
flow of 250 ml/min, using an AN69 dialyzer of 1.3 m2. pressure drop is remarkable and statistically significant
(P , 0.001). The same difference is observed when rela-The dialysate flow rate was 500 ml/min, and the dialysate
sodium content was 140 mEq/liter. Once established, the tive blood volume changes are considered. Greater varia-
tions are observed in DIHD compared with a fairly stabledesired weight loss time was scheduled on the basis of
a maximum ultrafiltration criterion. Ultrafiltration was behavior of the blood volume during CVVH (P , 0.001;
Fig. 4).set to not exceed 0.24 ml/min/kg body wt (approximately
1 liter/hr in a 70 kg patient). Bicarbonate was used as a In Figure 5, we report a typical example of a 48-hour
study in 1 of the 10 studied patients. It can be seen thatbuffer in dialysis fluid. The CVVH session was per-
formed with an AN69 hollow fiber hemofilter 0.6 m2, hemodynamic instability is only observed during DIHD,
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Fig. 2. Schematic representation of a typical
online blood volume monitor (Crit-Line; In-
line Diagnostics).
Table 4. Treatment parameters
DIHD CVVH
Total ultrafiltration 27806220 29106330
Ultrafiltration rate ml/min/kg 0.1960.3 0.02660.03
Blood flow rate ml/min 250615 200630
Treatment duration min 230615 1400680
Biochemical and clinical parameters
Pre-DIHD Post-DIHD Pre-CVVH Post-CVVH
Urea mg/dl 76.568.1 26.4 66.3 71.5 63.9 58.2 67.2
Creatinine mg/dl 8.362.6 3.2 61.4 7.8 61.7 6.3 61.3
Sodium mEq/liter 13763 139 64 137 63 139 62
Potassium mEq/liter 5.260.4 3.5 60.6 4.9 60.2 4.3 60.2
Chloride mEq/liter 5.264 10063 99 66 10364
Bicarbonate mmol/liter 19.363 26.9 62 20.1 62 24.9 62
Calcium mg/dl 8.960.4 10.660.6 9.0 60.2 9.7 60.5
Phosphate mg/dl 6.860.9 3.6 60.5 5.1 60.4 3.6 60.6
Osmolality mOsm/kgH2O 339610 285 610 334 612 320 613
Mean arterial pressure mm Hg 91613 79 68 90 612 92 610
Fig. 3. Peak of mean arterial pressure variation during the two different Fig. 4. Peak of relative blood volume change during the two different
treatment schedules. The mean arterial pressure reduction is signifi- treatment schedules. Blood volume changes reduction is significantly
cantly greater in intermittent daily hemodialysis. greater in intermittent daily hemodialysis.
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Fig. 5. Typical example of hemodynamic and blood vol-
ume monitoring in one of the studied patients. The patient
starts on CVVH and is shifted to DIHD on the next day.
The reduction in circulating blood volume and blood pres-
sure is remarkable during the intermittent treatment.
and this is directly correlated with a significant decrease their corrections. Using these systems, which of course
require a specific software and an adequate hardware,in circulating blood volume. In most cases, saline infusion
or plasma expander administration was required during the treatment carried out in the ICU could be followed
and controlled from the dialysis center, thus reducingDIHD, whereas no variation in substitution fluid admin-
istration rate was required during CVVH. the burden of sending dialysis nurses over to the ICU
at any blinking alarm or the need for substitution fluidTherefore, it seems that an accurate control of relative
blood volume changes may play a pivotal role in the bag change.
patient’s clinical tolerance to the treatment. Among the
different parameters, blood volume changes seem to be
BIOFEEDBACK SYSTEMSone of the most important to be monitored in real time.
Today, the availability of online signals from the pa-Not only could it suggest a discrepancy between ultrafil-
tient and from the CRRT machine allows an accuratetration and refilling, but it could also be applied to obtain
monitoring of the treatment and an adequate correctioninformation on patient’s hydration that is more complete
of clinical and technical problems. This, however, occursthan those offered by noninvasive hemodynamic param-
after a careful evaluation of the parameters obtained, aeters and/or Swan-Gantz catheters.
decision-making process that involves some latency, and
finally, the action carried out by the personnel to correct
TELEDIALYSIS AND REMOTE the problem. Newer systems have been used in the
DIALYSIS CONTROL chronic patient in an attempt to prevent the occurrence
of the problem [39, 40]. As an example, the online bloodIn several hospitals, the hemodialysis center is physi-
cally located at a distance from the ICU. Under these volume measurement joined with a continuous measure-
ment of the arterial pressure can be integrated in a multi-circumstances, it may become difficult to perform a 24-
hour renal replacement therapy. Dialysis nurses cannot input–multi-output controller that reacts in real time by
modifying the rate of ultrafiltration or the conductivityfollow the patient on a continuous basis and, on the other
hand, ICU nurses are not always sufficiently trained to of the dialysis solution. By setting a weight-loss target
over time, that is, a profile of allowed blood volumeperform the treatment completely. In spite of recent
advances in CRRT machines, in which large screens and change and other dialysis parameters, it is possible to
achieve an automatically controlled dialysis session infriendly user interface have been created to make the
nurse self-confident with the machine, the troubleshoot- which the maximal tolerance is ensured by the controller.
This actuates a real biofeedback loop in which not onlying procedure suggested by the software is not always
adequate to solve the problem at the patient’s bedside. the latency of the action is reduced or eliminated, but
in some cases, the problem is corrected before it becomesWe feel that an important step forward could be
played by a cable or modem-connected monitoring sys- clinically significant. This approach that until now has
been experimentally used in the chronic patient couldtem that permits the remote evaluation of alarms and
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become an important tool for the acute critically ill pa- such parameters is given by the newly emerging technol-
ogy. The accuracy of such measurement appears to betient undergoing CRRT.
enhanced, and this tool may become an important acces-
sory when performing renal replacement therapies in
DISCUSSION
the critically ill patient. Other online monitoring tools,
Cardiovascular instability is by far the most common although of some value in the chronic patient, may not
complication during extracorporeal renal replacement be of critical importance for the acute patient undergoing
therapies. This complication is even more evident in CRRT. Because of the continuous, long-lasting nature
critically ill patients affected by complicated forms of of CRRT, rapid variations of other important parameters
acute renal failure. Because the initial renal insult gener- are not likely to occur. Among the various monitoring
ally presents a condition of medullary ischemia as the systems, the BTM and the teledialysis approaches seem
common denominator, any condition that may induce to present some positive aspects and some appealing
further reduction to the perfusion of the kidney should features. The cost/benefit ratio of such devices has yet
be strongly prevented. In acute renal failure, the loss of to be understood.
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